GROUNDBREAKING RESEARCH

The AD109 Phase 3 Clinical Trial Program is Recruiting Participants with OSA

An Innovative Approach

With the Potential to Transform the Treatment of OSA

Apnimed is a clinical stage company

Developing novel therapies for sleep disorders

Apnimed is built upon a simple idea – patients with Obstructive Sleep Apnea (OSA) need a simple, safe and effective treatment that addresses the underlying biology of the disease. 

Obstructive Sleep Apnea

OSA and symptomatic snoring are serious disorders affecting millions in the U.S. and around the world.

Our Science

See how Apnimed can change the way we treat Obstructive Sleep Apnea.

Pipeline

Our therapies will change the way we treat Obstructive Sleep Apnea.